INTRODUCTION
Complications such as choroidal effusion as well as expulsive bleeding arise frequently in this condition [3, 5] . 
CASE REPORT
A 76-year-old female patient was referred to our clinic for consultation with eye reddening and glaucoma ''resistant to drug therapy''. Despite topical triple therapy, the IOP was above 30 mmHg on both sides. On an outpatient basis, an Nd:YAG laser iridotomy had been performed on both eyes, which showed no effect on IOP. In general, the patient suffered from arterial hypertension and atrial fibrillation. Initially, these general symptoms were not identified.
With a more focused interview, she reported tinnitus that persisted for the previous 6 years.
The IOP was in need of treatment for 3 years.
For the past year, the patient noticed an increasing reddening of both eyes. The patient could not recall past trauma. Connective tissue weakness had not been reported.
Ophthalmological examination showed a best corrected visual acuity of 1.0 (Snellen charts) on both sides. The IOP was 27 mmHg in both eyes. Slit lamp examination showed markedly dilated epibulbar vessels (Fig. 1a) . (Fig. 3) .
Threshold perimetry and measurement of the retinal nerve fiber layer did not indicate a disease progression.
DISCUSSION
CCF produces an intracranial arteriovenous shunt [6, 7] A retrospective multicenter investigation reports 14 eyes of 43 patients with CCF showing ocular manifestations [10] . Patients were recruited over 16 years. Of these about two-thirds developed secondary glaucoma. The most common symptom was conjunctival hyperemia (92.9%). Surgical fistula occlusion was done in only 4 of 9 cases. Here, three eyes had a good outcome of IOP control. If CCF closed spontaneously it was also predictive for good IOP outcome. Generally, anti-glaucoma treatments were more effective in eyes with CCF closure [10] . Therefore, these results may also focus on fistula closure as the primary therapy.
Currently, neuroradiological transluminal intervention is the therapy of choice. Over 90% of the fistulas can thereby be treated successfully [9] . Among the availabilities are fluid embolisates, coils or detachable balloons [9] [10] [11] [12] . Arterial or venous access is possible and interdisciplinary approaches are to be favored [12, 13] . Aside from a very low immediate risks (e.g., stroke), thrombosis of the cavernous sinus may occur after intervention, as in the reported case. To reduce the risk for such complications, temporary therapeutic heparinization is indicated [14] .
Patient support requires an interdisciplinary concept. For indication and evaluation, Ideally and for improved reliability, this should be performed over 48 h or longer, in particular if vascular factors are pathogenetically involved [16, 17] . 
